Plasma amyloid β, apolipoprotein E, lacunar infarcts, and white matter lesions

被引:94
作者
van Dijk, EJ
Prins, ND
Vermeer, SE
Hofman, A
van Duijn, CM
Koudstaal, PJ
Breteler, MMB
机构
[1] Erasmus Med Ctr, Dept Epidemiol & Biostat, NL-3000 DR Rotterdam, Netherlands
[2] Erasmus Med Ctr, Dept Neurol, NL-3000 DR Rotterdam, Netherlands
关键词
D O I
10.1002/ana.20050
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Lacunar brain infarcts and cerebral white matter lesions are frequently observed on magnetic resonance imaging scans in elderly subjects. These lesions are also frequent in patient with cerebral amyloid angiopathy. We examined whether plasma amyloid beta peptide (Abeta) levels are associated with lacunar infarcts and white matter lesions in the general population, and whether the apolipoprotein E (APOE) genotype modifies these associations. We studied 1,077 participants within the population-based Rotterdam Scan Study, who were 60 to 90 years of age and free of dementia. Crosssectional associations were analyzed by regression models with adjustments for age, sex, creatinine levels, and hypertension. In APOE epsilon4 carriers, plasma Abeta levels were positively associated with lacunar infarcts and white matter lesions, whereas in noncarriers no associations were observed. Per standard deviation increase in Abeta(1-40) and Abeta(1-42) levels the odds ratios for lacunar infarcts were 1.72 (95% confidence interval [CI] = 1.22-2.43) and 1.93 (95% CI = 1.31-2.85), the periventricular white matter lesion grade increased by 0.32 (95% CI = 0.08-0.57) and 0.29 (95% CI = 0.00-0-57), and the subcortical white matter lesion volume increased by 0.48ml (95% CI = 0.04-0.91) and 0.24ml (95% CI = -0.27-0.75). Higher Abeta levels are associated with more lacunar infarcts and white matter lesions in elderly subjects who carry an APOE epsilon4 allele.
引用
收藏
页码:570 / 575
页数:6
相关论文
共 37 条
[1]   Serum creatinine levels correlate with plasma amyloid β protein [J].
Arvanitakis, Z ;
Lucas, JA ;
Younkin, LH ;
Younkin, SG ;
Graff-Radford, NR .
ALZHEIMER DISEASE & ASSOCIATED DISORDERS, 2002, 16 (03) :187-190
[2]   Lack of apolipoprotein E dramatically reduces amyloid beta-peptide deposition [J].
Bales, KR ;
Verina, T ;
Dodel, RC ;
Du, YS ;
Altstiel, L ;
Bender, M ;
Hyslop, P ;
Johnstone, EM ;
Little, SP ;
Cummins, DJ ;
Piccardo, P ;
Ghetti, B ;
Paul, SM .
NATURE GENETICS, 1997, 17 (03) :263-264
[3]   Cleavage of amyloid precursor protein elicited by chronic cerebral hypoperfusion [J].
Bennett, SAL ;
Pappas, BA ;
Stevens, WD ;
Davidson, CM ;
Fortin, T ;
Chen, J .
NEUROBIOLOGY OF AGING, 2000, 21 (02) :207-214
[4]   Hereditary cerebral hemorrhage with amyloidosis-Dutch type (HCHWA-D) .1. A review of clinical, radiologic and genetic aspects [J].
Bornebroek, M ;
Haan, J ;
MaatSchieman, MLC ;
VanDuinen, SG ;
Roos, RAC .
BRAIN PATHOLOGY, 1996, 6 (02) :111-114
[5]   A WHITE MATTER DISORDER IN DEMENTIA OF THE ALZHEIMER TYPE - A PATHOANATOMICAL STUDY [J].
BRUN, A ;
ENGLUND, E .
ANNALS OF NEUROLOGY, 1986, 19 (03) :253-262
[6]   Cerebral beta amyloid angiopathy is a risk factor for cerebral ischemic infarction. A case control study in human brain biopsies [J].
Cadavid, D ;
Mena, E ;
Koeller, K ;
Frommelt, RA .
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 2000, 59 (09) :768-773
[7]   Neuronal overexpression of mutant amyloid precursor protein results in prominent deposition of cerebrovascular amyloid [J].
Calhoun, ME ;
Burgermeister, P ;
Phinney, AL ;
Stalder, M ;
Tolnay, M ;
Wiederhold, KH ;
Abramowski, D ;
Sturchler-Pierrat, C ;
Sommer, B ;
Staufenbiel, M ;
Jucker, M .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (24) :14088-14093
[8]  
de Leeuw FE, 1999, ANN NEUROL, V46, P827, DOI 10.1002/1531-8249(199912)46:6<827::AID-ANA4>3.0.CO
[9]  
2-H
[10]   Plaque-associated disruption of CSF and plasma amyloid-β (Aβ) equilibrium in a mouse model of Alzheimer's disease [J].
DeMattos, RB ;
Bales, KR ;
Parsadanian, M ;
O'Dell, MA ;
Foss, EM ;
Paul, SM ;
Holtzman, DM .
JOURNAL OF NEUROCHEMISTRY, 2002, 81 (02) :229-236